Acknowledgements
David A. Flockhart, MD, PhD
Director, Division of Clinical Pharmacology Indiana University School
of Medicine
Sally Usdin Yasuda, MS, PharmD
Assistant Professor Department of Pharmacology Georgetown University School
of Medicine
Funded by 1 U18 HS 10385-01 from Agency for Healthcare Research and Quality
Director, Office of Postmarketing Drug Risk Assessment U.S. Food and Drug Administration
- Curtis Rosebraugh, MD, MPH
Medical Officer, Division of Pulmonary and Allergy Drug Products Food and Drug Administration
Raymond L. Woosley, MD, PhD
Vice President for Health Sciences, University of Arizona Director, Arizona CERT